| Marina Ivashchenko, Md, Pc | |
|
9898 Rosemont Ave Bldg 4, Suite 104 Lone Tree CO 80124-4107 | |
| (303) 799-7978 | |
| (303) 790-4045 |
| Full Name | Marina Ivashchenko, Md, Pc |
|---|---|
| Speciality | Clinic/Center |
| Location | 9898 Rosemont Ave, Lone Tree, Colorado |
| Authorized Official Name and Position | Marina Ivashchenko (PRESIDENT) |
| Authorized Official Contact | 3037997978 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Marina Ivashchenko, Md, Pc 9898 Rosemont Ave Bldg 4, Suite 104 Lone Tree CO 80124-4107 Ph: (303) 799-7978 | Marina Ivashchenko, Md, Pc 9898 Rosemont Ave Bldg 4, Suite 104 Lone Tree CO 80124-4107 Ph: (303) 799-7978 |
| NPI Number | 1316251929 |
|---|---|
| Provider Enumeration Date | 08/06/2010 |
| Last Update Date | 10/01/2013 |
| Medicare PECOS PAC ID | 1951425784 |
|---|---|
| Medicare Enrollment ID | O20100901000136 |
News Archive
The Muscular Dystrophy Association today heralds a landmark muscular dystrophy advance by an international study team of scientists and physicians from the Netherlands, United States, France and Spain. Led by MDA-grantee Silvère van der Maarel, Ph.D., at Leiden University Medical Center in the Netherlands, the collaborative study of more than 2,300 people found that two distinct genetic changes on chromosome 4 must be present to cause facioscapulohumeral muscular dystrophy (FSHD).
In the latest issue of the renowned scientific journal "Nature" researchers from the universities of Freiburg and Basel report on their discovery of previously unknown subunits of the GABAB receptors in the central nervous system. GABAB receptors are transmembrane proteins in nerve cells which are of fundamental significance for the functioning of the brain and have great therapeutical and pharmaceutical importance.
With the realization that half of the people experiencing a sudden mortal heart attack were taking aspirin on the day of their demise, and the fact that higher-than-recommended doses of aspirin are needed to prevent blood clot formation in coronary arteries, coupled with an announcement that the red wine molecule resveratrol (rez-vair-ah-trawl) may protect from sudden mortal heart attack in a superior fashion to aspirin, suggests re-evaluation of cardiology's current instruction regarding prevention of heart attacks, says Nate Lebowitz MD, cardiologist with the Advanced Cardiology Institute in Ft. Lee, New Jersey.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316251929 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Marina Alexander Ivashchenko |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1235276593 PECOS PAC ID: 2860516697 Enrollment ID: I20100901000195 |
News Archive
The Muscular Dystrophy Association today heralds a landmark muscular dystrophy advance by an international study team of scientists and physicians from the Netherlands, United States, France and Spain. Led by MDA-grantee Silvère van der Maarel, Ph.D., at Leiden University Medical Center in the Netherlands, the collaborative study of more than 2,300 people found that two distinct genetic changes on chromosome 4 must be present to cause facioscapulohumeral muscular dystrophy (FSHD).
In the latest issue of the renowned scientific journal "Nature" researchers from the universities of Freiburg and Basel report on their discovery of previously unknown subunits of the GABAB receptors in the central nervous system. GABAB receptors are transmembrane proteins in nerve cells which are of fundamental significance for the functioning of the brain and have great therapeutical and pharmaceutical importance.
With the realization that half of the people experiencing a sudden mortal heart attack were taking aspirin on the day of their demise, and the fact that higher-than-recommended doses of aspirin are needed to prevent blood clot formation in coronary arteries, coupled with an announcement that the red wine molecule resveratrol (rez-vair-ah-trawl) may protect from sudden mortal heart attack in a superior fashion to aspirin, suggests re-evaluation of cardiology's current instruction regarding prevention of heart attacks, says Nate Lebowitz MD, cardiologist with the Advanced Cardiology Institute in Ft. Lee, New Jersey.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
› Verified 9 days ago
News Archive
The Muscular Dystrophy Association today heralds a landmark muscular dystrophy advance by an international study team of scientists and physicians from the Netherlands, United States, France and Spain. Led by MDA-grantee Silvère van der Maarel, Ph.D., at Leiden University Medical Center in the Netherlands, the collaborative study of more than 2,300 people found that two distinct genetic changes on chromosome 4 must be present to cause facioscapulohumeral muscular dystrophy (FSHD).
In the latest issue of the renowned scientific journal "Nature" researchers from the universities of Freiburg and Basel report on their discovery of previously unknown subunits of the GABAB receptors in the central nervous system. GABAB receptors are transmembrane proteins in nerve cells which are of fundamental significance for the functioning of the brain and have great therapeutical and pharmaceutical importance.
With the realization that half of the people experiencing a sudden mortal heart attack were taking aspirin on the day of their demise, and the fact that higher-than-recommended doses of aspirin are needed to prevent blood clot formation in coronary arteries, coupled with an announcement that the red wine molecule resveratrol (rez-vair-ah-trawl) may protect from sudden mortal heart attack in a superior fashion to aspirin, suggests re-evaluation of cardiology's current instruction regarding prevention of heart attacks, says Nate Lebowitz MD, cardiologist with the Advanced Cardiology Institute in Ft. Lee, New Jersey.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
› Verified 9 days ago
Advanced Integrative Medicine, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10455 Park Meadows Dr, Suite 102, Lone Tree, CO 80124 Phone: 303-708-0246 Fax: 303-708-0247 | |
Colorado Endocrinology, Thyroid And Diabetes Consultants, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10099 Ridgegate Pkwy, Suite 480, Lone Tree, CO 80124 Phone: 303-790-2400 Fax: 303-790-2408 | |
Quantum Specialist Network Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9777 S Yosemite St Ste 220, Lone Tree, CO 80124 Phone: 720-560-3083 | |
Heritage Hills Family Medicine, P.c Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9218 Kimmer Dr, Suite 102, Lone Tree, CO 80124 Phone: 303-792-3333 Fax: 303-792-3361 | |
University Of Colorado Hospital Authority Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9544 Park Meadows Dr Ste 100, Lone Tree, CO 80124 Phone: 720-553-1200 | |
Mark Perea Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9894 Rosemont Ave Ste 103, Lone Tree, CO 80124 Phone: 303-792-0799 | |
University Of Colorado Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9540 Park Meadows Dr, Lone Tree, CO 80124 Phone: 720-848-9300 |